Get started
Author

Mahesh Abhyankar

Observed names: M Abhyankar, MAHESH ABHYANKAR, MAHESH Abhyankar, MAHESH V. ABHYANKAR, Mahesh V Abhyankar, Mahesh V. Abhyankar, Mahesh Vasant Abhyankar
Institution: USV (India)
Observed institutions: Apollo Hospitals, Ipca Laboratories (India), Ruby Hall Clinic, CARE Hospitals, Maharani Laxmi Bai Medical College, Krishna Institute of Medical Sciences, Diacon Hospital, USV (India), AMRI Hospitals
ORCID: 0000-0003-3127-0575
Observed ORCID: 0000-0003-3127-0575
OpenAlex ID: A5055767770
Management of Diabetic Foot in an Indian Clinical Setup: An Opinion Survey
2020 · Ashok Das, Sharad Pendsey, et al. · Cureus · 32
PDF
Glimepiride and Metformin Combinations in Diabetes Comorbidities and Complications: Real-World Evidence
2020 · Rakesh Kumar Sahay, Vinod Mittal, et al. · Cureus · 31
PDF
Cardiac rehabilitation knowledge, awareness, and practice among cardiologists in India
2018 · Gabriela Lima de Melo Ghisi, Aashish Contractor, et al. · Indian Heart Journal · 17
PDF
Risk Factors and Comorbidities in Young Indian Patients with Hypertension: REAL YOUNG (Hypertension) Study
2021 · Nagaraj Desai, Govindan Unni, et al. · Integrated Blood Pressure Control · 15
PDF
Real-World Observational Study of Glimepiride and Metformin Fixed-Dose Combination Along With Insulin in the Management of Type 2 Diabetes Mellitus: Indian Experience
2021 · KM Prasanna Kumar, Krishna Seshadri, et al. · Cureus · 10
PDF
Real-World Clinical Experience on the Usage of High-Dose Metformin (1500-2500 mg/day) in Type 2 Diabetes Management
2021 · Ashok Kumar Das, Sanjiv Shah, et al. · Clinical Medicine Insights Endocrinology and Diabetes · 10
Resurgence of hypertension and cardiovascular diseases in patients recovered from COVID-19: An Indian perspective
2022 · Bhaskaran Krishnakumar, Johann Christopher, et al. · Journal of Family Medicine and Primary Care · 8
Risk factors, comorbiditiEs and Atherogenic dysLipidaemia in Indian YOUNG patients with dyslipidaemia attending hospital/clinic: REAL YOUNG (dyslipidaemia) study
2020 · S. S. Iyengar, S. N. Narasingan, et al. · Journal of Family Medicine and Primary Care · 8
Expert Opinion About the Pharmacoeconomic Edge of Low-Cost Dapagliflozin in Type 2 Diabetes Mellitus in Indian Clinical Settings
2021 · Kamal Sharma, A B Chandorkar, et al. · Cureus · 7
PDF
Immunomodulatory Effect of a Polyherbal Formulation (Imusil) on Cyclophosphamide Induced Experimental Animal Model
2023 · Ratheesh M, Sheethal S, et al. · Asian Pacific Journal of Cancer Prevention · 5
PDF
Clinical Utility of Glimepiride and Metformin Fixed-Dose Combination in Obese/Overweight Patients with Type 2 Diabetes Mellitus in Indian Settings
2022 · Binayak Sinha, Saket Kant, et al. · Chronicle of Diabetes Research and Practice · 4
Moisturizing and antioxidant factors of skin barrier restoring cream with shea butter, silkflo and vitamin E in human keratinocyte cells
2024 · Ratheesh Mohanan, Svenia P. Jose, et al. · International Journal of Cosmetic Science · 3
Expert Consensus on Triple Combination of Glimepiride, Metformin, and Voglibose Usage in Patients with Type 2 Diabetes Mellitus in Indian Settings
2022 · Ashok K. Das, Subhash K. Wangnoo, et al. · Journal of Diabetology · 3
Management of American Heart Association/American College of Cardiology-Defined Stage 2 Hypertension by Cardiologists in India
2022 · C Venkata S Ram, Jamshed Dalal, et al. · The American Journal of Cardiology · 2
Assessment of Clinical Experience of Triple Drug Fixed-dose Combination of Glimepiride, Metformin and Voglibose in the Management of Type 2 Diabetes Mellitus: A Retrospective Study
2021 · Ganapathi Bantwal, Vageesh Ayyar, et al. · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · 2
Insulin sparing effect of hydroxychloroquine in uncontrolled diabetes mellitus
2016 · Mahesh Virayya Padsalge, Mahesh Vasant Abhyankar, et al. · Clinical Diabetology · 2
PDF
Complex of zinc and lectins from seeds of Vigna radiata as potential anti-diabetic agent
2015 · Chhaya Gadgoli, Lalit Sali, et al. · International Electronic Conference on Medicinal Chemistry (ECMC) · 2
Evaluation of Deficiency of Vitamin D and Advantages of Supplementation of Vitamin D in COVID-19 Infections: A Narrative Review
2025 · Ashu Rastogi, Jaya P Sahoo, et al. · Journal of the Association of Physicians of India · 1
The Efficacy and Safety of Imusil® Tablets in the Treatment of Adult Patients With Mild COVID-19: A Prospective, Randomized, Multicenter, Open-Label Study
2023 · Mahesh Abhyankar, Dilip Kadam, et al. · Cureus · 1
PDF
Blood pressure variability in hypertension patients in Indian clinical settings
2022 · M Abhyankar, A K Jinghan, et al. · European Heart Journal · 1
PDF
Real-world experience of clinical management with antiplatelet and lipid-lowering therapy in post acute coronary syndrome patients in Indian setting
2021 · M.S. HIREMATH, S. N. ROUTRAY, et al. · Heart India · 1
Triple drug therapy to manage uncontrolled BP in hypertensive patients during Covid-19 lockdown: perspectives from India
2021 · MAHESH Abhyankar, SHARAD Kumar, et al. · European Journal of Cardiovascular Nursing · 1
PDF
An indian clinician outlook on hypertension care during Covid-19 pandemic
2021 · M Abhyankar, B Majumder, et al. · European Journal of Preventive Cardiology · 1
PDF
Hypertension clinical care in the era of coronavirus disease 2019: Practical insights from India
2023 · MANGESH TIWASKAR, PRABHAKAR C KOREGOL, et al. · Heart India
Challenges for Effective Glycemic control in T2DM during Covid-19 pandemic and Use of Glimepiride/Metformin FDC: Opinion from Indian Clinicians
2022 · Alka Gandhi, C.R. Anand Moses, et al. · Metabolism
PDF
Works count: 32
Citation count: 167
H-index: 8
I10-index: 6
Year
Topic
Type